Evaluating Nitrosamines from Elastomers in Pharmaceutical Primary Packaging

Area of Science:

• Pharmaceutical Chemistry
• Drug Safety
• Materials Science

Background:

• Nitrosamines are a class of chemical compounds that have recently been detected at high levels in pharmaceutical products.
• Regulatory bodies now mandate nitrosamine risk assessments for drug development and marketed products.
• Evaluating all potential nitrosamine sources is crucial for comprehensive risk management.

Purpose of the Study:

• To provide a chemical overview of nitrosamines and elastomeric formulations.
• To discuss the current regulatory landscape for nitrosamines across industries.
• To explore the analytical difficulties in measuring nitrosamines.

Main Methods:

• Literature review of nitrosamine chemistry and elastomeric materials.
• Analysis of current regulatory guidelines for pharmaceuticals and other sectors.
• Discussion of analytical methodologies for nitrosamine detection and quantification.

Main Results:

• Elastomeric components in drug packaging are identified as a potential source of nitrosamine contamination.
• The chemical interactions between nitrosamines and elastomeric formulations are detailed.
• Analytical challenges in detecting low-level nitrosamines are highlighted.

Conclusions:

• Elastomeric materials require careful consideration as a potential nitrosamine source in pharmaceutical risk assessments.
• Understanding the chemical basis and analytical methods is key to mitigating nitrosamine risks.
• This review offers a framework for incorporating elastomeric component evaluation into drug product safety assessments.